Loading...
M T Madon Exports — Mitomycin Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #11 for Mitomycin · $36.2K export value · DGFT Verified
M T Madon Exports is the #11 Indian exporter of Mitomycin with $36.2K in export value and 18 verified shipments. M T Madon Exports holds a 0.4% market share in Mitomycin exports across 7 countries. The company exports 6 pharmaceutical products worth $75.8K across 4 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $5.2M | 133 | 70.7% |
| ALGERIA | $450.0K | 9 | 6.1% |
| THAILAND | $427.5K | 15 | 5.8% |
| JAPAN | $300.0K | 6 | 4.1% |
| VENEZUELA | $172.2K | 6 | 2.4% |
| POLAND | $157.2K | 53 | 2.1% |
| IRAQ | $152.2K | 98 | 2.1% |
| SAUDI ARABIA | $95.2K | 41 | 1.3% |
| UNITED ARAB EMIRATES | $78.4K | 81 | 1.1% |
| UNITED KINGDOM | $67.8K | 8 | 0.9% |
India exports Mitomycin to 103 countries. The top destination is UNITED STATES (70.7%), followed by ALGERIA and THAILAND.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| RX CROSSROADS 3PL LLC | UNITED STATES | $1.1M | 21 |
| EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $290.9K | 15 |
| EUGIA US LLC | UNITED STATES | $242.5K | 5 |
| ATLANTA MEDICARE CO LTD | THAILAND | $226.0K | 9 |
| RXCROSSROADS 3PL LLC | UNITED STATES | $200.0K | 4 |
| PHARMACIE CENTRALE DES HOPITAUX (PC |
India exported $5.6M worth of Mitomycin through 1,333 shipments from 213 suppliers to 103 countries, serving 456 buyers globally. M T Madon Exports contributes $36.2K to this total, accounting for 0.4% of India's Mitomycin exports.
M T Madon Exports's average Mitomycin shipment value is $2.0K per consignment, based on 18 shipments totaling $36.2K.
M T Madon Exports ranks #11 among 213 Indian Mitomycin exporters with a 0.4% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($2.3M), MYLAN LABORATORIES LIMITED ($1.3M), NAPROD LIFE SCIENCES PRIVATE LIMITED ($738.6K). M T Madon Exports processed 18 shipments to 7 destination countries.
What M T Madon Exports must comply with to export Mitomycin to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | DISTINCT IMPEX PRIVATE LIMITED | $50.7K | 9 | 2 | $5.6K |
| 10 | DHEER HEALTH CARE PRIVATE LIMITED | $44.3K | 5 | 1 | $8.9K |
| 11 | M T MADON EXPORTS ★ | $36.2K | 18 | 7 | $2.0K |
| 12 | RAVI PHARMA | $36.2K | 21 | 1 | $1.7K |
M T Madon Exports ranks among 213 Indian Mitomycin exporters.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 341 | 25.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 261 | 19.6% |
| Bombay Air | 104 | 7.8% |
| DELHI AIR | 91 | 6.8% |
| DELHI AIR CARGO ACC (INDEL4) | 72 | 5.4% |
| AHEMDABAD AIR ACC (INAMD4) | 62 | 4.7% |
| AHEMDABAD AIR | 55 | 4.1% |
| Bombay Air Cargo | 43 | 3.2% |
M T Madon Exports also exports these advanced oncology products. Each links to the detailed product page.
M T Madon Exports exports 6 products worth $75.8K. Beyond Mitomycin, top products include Sulfasalazine, Ibrutinib, Streptomycin, Canagliflozin, Repaglinide. View the complete M T Madon Exports profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Mitomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for M T Madon Exports's Mitomycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
M T Madon Exports
Full Company Profile →
6 products · $75.8K total trade · 4 categories
| ALGERIA |
| $200.0K |
| 4 |
| FOUNDATION CARE | UNITED STATES | $150.0K | 3 |
| B BRAUN MEDICAL INC | UNITED STATES | $150.0K | 3 |
| KYOWA KIRIN CO LTD | JAPAN | $150.0K | 3 |
| ATLANTA MEDICARE CO. LTD. | THAILAND | $149.1K | 4 |
India's Mitomycin is purchased by 456 buyers worldwide. The top buyer is RX CROSSROADS 3PL LLC (UNITED STATES), followed by EVERSANA LIFE SCIENCES SERVICES,LLC and EUGIA US LLC.
Generic Drug Application per Japan Pharmaceutical Affairs Act. Dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Timeline: 12–24 months
GMP & Export Requirements
Japanese GMP (J-GMP); PMDA on-site inspection of Indian manufacturing facility
Foreign Manufacturer Accreditation from PMDA; Japanese MAH (Marketing Authorization Holder) partner required
Note: Japan requires Yen-denominated NHI drug price listing. Stability data under ICH Zone IVb conditions.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 103+ countries, 456+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for M T Madon Exports.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mitomycin. For current shipment-level data, contact TransData Nexus.